A brief look at our programs
Advertisement
Algorithm distinguishes between benign and malignant masses
The technology could reduce complications by offering patients an alternative to open liver surgeries
The role of interventional pulmonology in cancer care
Results of two studies presented at the 2020 ASH Annual Meeting
In search of improved outcomes for patients
Overall survival extended by approximately 12 months
An overview of our leading-edge diagnostics and therapeutics
The physician scientist discusses her vision for the program
Advertisement
Advertisement